Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 26 October 2023 to Question 203835 on Attention Deficit Hyperactivity Disorder: Drugs, when she expects to see ADHD Medication availability return to its regular levels.

The Department has been working closely with the respective manufacturers of medicine used for attention deficit hyperactivity disorder (ADHD). Some issues have now been resolved; however, we know that there continue to be disruptions to the supply of some other medicines, which should resolve by April 2024.

We have well-established processes to manage supply issues and continue to work with the respective manufacturers and all relevant stakeholders to ensure that the supply disruptions are resolved as soon as possible.

We understand how frustrating and distressing medicine shortages can be and we want to assure patients that we are working with the respective manufacturers to resolve the issues with ADHD medicine supply in the United Kingdom as soon as possible and to help ensure patients are able to access these medicines in the short and long term.